AmnioWrap2 is a minimally manipulated, dehydrated human tissue membrane comprised of the naturally occurring amnion, chorion, and intact intermediate layers
INTENDED USES: is intended for the treatment of wounds, including lower extremity ulceration caused by diabetes, chronic venous disease, and other chronic conditions. Acute wounds involving the dermal tissue layer may be appropriate for treatment with AnmioWrap2.
CLAIMED BENEFITS: Acts as a barrier; Easy to handle and conforms to the application site; Provides an environment to repair, reconstruct, and replace tissue
OPTION: AmnioWrap2 is provided dry in a double foil sterile pouch. It is available in various sizes, from 1 x 1 cm to 10 x 12 cm.
AW2-0204: AmnioWrap2, 2cm x 4cm:Q4221
AW2-0303: AmnioWrap2, 3cm x 3cm:Q4221
AW2-0404: AmnioWrap2, 4cm x 4cm:Q4221
AW2-0406: AmnioWrap2, 4cm x 6cm:Q4221
AW2-0408: AmnioWrap2, 4cm x 8cm:Q4221
Manufacturer: Direct Biologics
Information retrieved from manufacturer and/or FDA-approved labels